22-24 in Las Vegas, NV, bringing together researchers and clinicians to share new findings in inflammatory bowel disease (IBD) ...Real-world studies link GLP-1 drugs to improved IBD outcomes ... IBD, therapy, and fertility ... Learn more about IBD..
PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing significant unmet needs in ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) ... .
The holiday season brings festive meals, sugary drinks and a break from routine - but for people living with inflammatory bowel disease (IBD), this time of year can be especially challenging.
"IBDMouseModels". Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates ... Ace Therapeutics offers a diverse portfolio of IBD animal models to suit every research need, including..
Many Indians dismiss chronic gut problems as IBS, but experts warn it could be IBD. Learn the key differences, red-flag symptoms, and why early diagnosis is crucial ....
The findings could lead to new treatments for inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis ... IBD affects millions worldwide, and current treatments often focus ...
This premier meeting brings together the leading voices in inflammatory bowel disease (IBD) to highlight breakthrough research, innovative technologies, and forward-thinking approaches to patient care ... Advancing New IBD Therapeutic Modalities.